Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

References

• Abramovic, I., Ulamec, M., Katusic Bojanac, A., Bulic-Jakus, F., Jezek, D., & Sincic, N. (2020). miRNA in prostate cancer: Challenges toward translation. Epigenomics, 12(6), 543–558. https://doi.org/10.2217/epi-2019-0275
   PubMed Web of Science ®Google Scholar
• Afonso, M. B., Rodrigues, P. M., Simão, A. L., & Castro, R. E. (2016). Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma. Journal of Clinical Medicine, 5(3), 30. https://doi.org/10.3390/jcm5030030
   Web of Science ®Google Scholar
• Al-Shaheri, F. N., Alhamdani, M. S. S., Bauer, A. S., Giese, N., Büchler, M. W., Hackert, T., & Hoheisel, J. D. (2021). Blood biomarkers for differential diagnosis and early detection of pancreatic cancer. Cancer Treatment Reviews, 96, 102193. https://doi.org/10.1016/j.ctrv.2021.102193
   Web of Science ®Google Scholar
• Armand-Labit, V., & Pradines, A. (2017). Circulating cell-free microRNAs as clinical cancer biomarkers. Biomolecular Concepts, 8(2), 61–81. https://doi.org/10.1515/bmc-2017-0002
   PubMedGoogle Scholar
• Asano, N., Matsuzaki, J., Ichikawa, M., Kawauchi, J., Takizawa, S., Aoki, Y., Sakamoto, H., Yoshida, A., Kobayashi, E., Tanzawa, Y., Nakayama, R., Morioka, H., Matsumoto, M., Nakamura, M., Kondo, T., Kato, K., Tsuchiya, N., Kawai, A., & Ochiya, T. (2019). A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes. Nature Communications, 10(1), 1299. https://doi.org/10.1038/s41467-019-09143-8
   PubMed Web of Science ®Google Scholar
• Beheshti, A., Stevenson, K., Vanderburg, C., Ravi, D., McDonald, J. T., Christie, A. L., Shigemori, K., Jester, H., Weinstock, D. M., & Evens, A. M. (2019). Identification of circulating serum multi-microRNA signatures in human DLBCL models. Scientific Reports, 9(1), 17161. https://doi.org/10.1038/s41598-019-52985-x
   Google Scholar
• Cancer, W. I. A. (2020). Estimated number of deaths in 2020, all cancers, both sexes, all ages. Cancer today.
   Google Scholar
• Carter, J. V., Galbraith, N. J., Yang, D., Burton, J. F., Walker, S. P., & Galandiuk, S. (2017). Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: A systematic review and meta-analysis. British Journal of Cancer, 116(6), 762–774. https://doi.org/10.1038/bjc.2017.12
   PubMed Web of Science ®Google Scholar
• Cinque, A., Vago, R., & Trevisani, F. (2021). Circulating RNA in kidney cancer: what we know and what we still suppose. Genes, 12(6), 835. https://doi.org/10.3390/genes12060835
   PubMed Web of Science ®Google Scholar
• Cirillo, P. D. R., Margiotti, K., Fabiani, M., Barros-Filho, M. C., Sparacino, D., Cima, A., Longo, S. A., Cupellaro, M., Mesoraca, A., & Giorlandino, C. (2021). Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection. PloS One, 16(8), e0255804. https://doi.org/10.1371/journal.pone.0255804
   Web of Science ®Google Scholar
• Coradduzza, D., Cruciani, S., Arru, C., Garroni, G., Pashchenko, A., Jedea, M., Zappavigna, S., Caraglia, M., Amler, E., Carru, C., & Maioli, M. (2022). Role of miRNA-145, 148, and 185 and stem cells in prostate cancer. International Journal of Molecular Sciences, 23(3), 1626. https://doi.org/10.3390/ijms23031626
   Web of Science ®Google Scholar
• Chen, B., Xia, Z., Deng, Y. N., Yang, Y., Zhang, P., Zhu, H., Xu, N., & Liang, S. (2019). Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis. Open Biology, 9(1), 180212. https://doi.org/10.1098/rsob.180212
   PubMed Web of Science ®Google Scholar
• Chen, J. W., & Dhahbi, J. (2022). Identification of four serum miRNAs as potential markers to screen for thirteen cancer types. PloS One, 17(6), e0269554. https://doi.org/10.1371/journal.pone.0269554
   Web of Science ®Google Scholar
• Cheng, J., Meng, J., Zhu, L., & Peng, Y. (2020). Exosomal noncoding RNAs in glioma: Biological functions and potential clinical applications. Molecular Cancer, 19(1), 66. https://doi.org/10.1186/s12943-020-01189-3
   PubMed Web of Science ®Google Scholar
• Deb, B., Uddin, A., & Chakraborty, S. (2018). miRNAs and ovarian cancer: An overview. Journal of Cellular Physiology, 233(5), 3846–3854. https://doi.org/10.1002/jcp.26095
   PubMed Web of Science ®Google Scholar
• Decruyenaere, P., Offner, F., & Vandesompele, J. (2021). Circulating RNA biomarkers in diffuse large B-cell lymphoma: A systematic review. Experimental Hematology & Oncology, 10(1), 13. https://doi.org/10.1186/s40164-021-00208-3
   Web of Science ®Google Scholar
• Dong, C., Wu, J., Chen, Y., Nie, J., & Chen, C. (2021). Activation of PI3K/AKT/mTOR pathway causes drug resistance in breast cancer. Frontiers in Pharmacology, 12, 628690. https://doi.org/10.3389/fphar.2021.628690
   PubMed Web of Science ®Google Scholar
• Dong, H., Wu, Y. L., Zhang, X., Li, H. L., & Zheng, W. H. (2023). MicroRNA-575 targets Derlin 1 to regulate proliferation, migration and invasion of human thyroid cancer cells. Archives of Medical Science: AMS, 19(4), 1108–1115. https://doi.org/10.5114/aoms.2020.92867
   Web of Science ®Google Scholar
• Du, X., Zhang, J., Wang, J., Lin, X., & Ding, F. (2018). Role of miRNA in lung cancer-potential biomarkers and therapies. Current Pharmaceutical Design, 23(39), 5997–6010. https://doi.org/10.2174/1381612823666170714150118
   PubMed Web of Science ®Google Scholar
• Elghoroury, E. A., ElDine, H. G., Kamel, S. A., Abdelrahman, A. H., Mohammed, A., Kamel, M. M., & Ibrahim, M. H. (2018). Evaluation of miRNA-21 and miRNA Let-7 as prognostic markers in patients with breast cancer. Clinical Breast Cancer, 18(4), e721–e726. https://doi.org/10.1016/j.clbc.2017.11.022
   PubMed Web of Science ®Google Scholar
• Endzeliņš, E., Melne, V., Kalniņa, Z., Lietuvietis, V., Riekstiņa, U., Llorente, A., & Linē, A. (2016). Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: A systematic review. Molecular Cancer, 15(1), 41. https://doi.org/10.1186/s12943-016-0523-5
   PubMedGoogle Scholar
• Esmail, H., Lai, R. P., Lesosky, M., Wilkinson, K. A., Graham, C. M., Horswell, S., Coussens, A. K., Barry, C. E., O'Garra, A., & Wilkinson, R. J. (2018). Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis. Proceedings of the National Academy of Sciences of the United States of America, 115(5), E964–E973. https://doi.org/10.1073/pnas.1711853115
   PubMed Web of Science ®Google Scholar
• Fabris, L., Ceder, Y., Chinnaiyan, A. M., Jenster, G. W., Sorensen, K. D., Tomlins, S., Visakorpi, T., & Calin, G. A. (2016). The potential of microRNAs as prostate cancer biomarkers. European Urology, 70(2), 312–322. https://doi.org/10.1016/j.eururo.2015.12.054
   PubMed Web of Science ®Google Scholar
• Fadhal, E. (2023). A comprehensive analysis of the PI3K/AKT pathway: Unveiling key proteins and therapeutic targets for cancer treatment. Cancer Informatics, 22, 11769351231194273. https://doi.org/10.1177/11769351231194273
   Web of Science ®Google Scholar
• Gailhouste, L., Gomez-Santos, L., & Ochiya, T. (2013). Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer. Frontiers in Bioscience (Landmark Edition), 18(1), 199–223. https://doi.org/10.2741/4096
   Google Scholar
• Galvão-Lima, L. J., Morais, A. H. F., Valentim, R. A. M., & Barreto, E. J. S. S. (2021). miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools. BioMedical Engineering OnLine, 20(1), 21. https://doi.org/10.1186/s12938-021-00857-9
   Web of Science ®Google Scholar
• Garcia, C. M., & Toms, S. A. (2020). The role of circulating microRNA in glioblastoma liquid biopsy. World Neurosurgery, 138, 425–435. https://doi.org/10.1016/j.wneu.2020.03.128
   PubMed Web of Science ®Google Scholar
• Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., Geoerger, B., Kulke, M. H., Baird, R. D., Prabhu, J. S., Carbone, D., Pecoraro, C., Teh, D. B. L., Sethi, G., Cavalieri, V., Lin, K. H., … Kumar, A. P. (2023). PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Molecular Cancer, 22(1), 138. https://doi.org/10.1186/s12943-023-01827-6
   Web of Science ®Google Scholar
• Gray, A., Cui, T., Bell, E. H., McElroy, J., Sebastian, E., Li, F., Geurts, M., Liu, K., Robe, P., Haque, S. J., & Chakravarti, A. (2022). MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma. Experimental and Molecular Pathology, 128, 104813. https://doi.org/10.1016/j.yexmp.2022.104813
   Web of Science ®Google Scholar
• Ghafouri-Fard, S., Shoorei, H., & Taheri, M. (2020). miRNA profile in ovarian cancer. Experimental and Molecular Pathology, 113, 104381. https://doi.org/10.1016/j.yexmp.2020.104381
   PubMed Web of Science ®Google Scholar
• Ghareib, A. F., Mohamed, R. H., Abd El-Fatah, A. R., & Saadawy, S. F. (2020). Assessment of serum microRNA-21 gene expression for diagnosis and prognosis of colorectal cancer. Journal of Gastrointestinal Cancer, 51(3), 818–823. https://doi.org/10.1007/s12029-019-00306-w
   PubMed Web of Science ®Google Scholar
• Han, Y., Zhang, H., Zhou, Z., Liu, R., Liu, D., Bai, M., Fan, Q., Li, J., Zhu, K., Li, H., Ning, T., Ying, G., & Ba, Y. (2021). Serum microRNAs as biomarkers for the noninvasive early diagnosis of biliary tract cancer. International Journal of General Medicine, 14, 1185–1195. https://doi.org/10.2147/IJGM.S297371
   PubMed Web of Science ®Google Scholar
• Heinemann, F. G., Tolkach, Y., Deng, M., Schmidt, D., Perner, S., Kristiansen, G., Müller, S. C., & Ellinger, J. (2018). Serum miR-122-5p and miR-206 expression: Non-invasive prognostic biomarkers for renal cell carcinoma. Clinical Epigenetics, 10(1), 11. https://doi.org/10.1186/s13148-018-0444-9
   PubMed Web of Science ®Google Scholar
• Hetta, H. F., Zahran, A. M., Shafik, E. A., El-Mahdy, R. I., Mohamed, N. A., Nabil, E. E., Esmaeel, H. M., Alkady, O. A., Elkady, A., Mohareb, D. A., Hosni, A., Mostafa, M. M., & Elkady, A. (2019). Circulating miRNA-21 and miRNA-23a expression signature as potential biomarkers for early detection of non-small-cell lung cancer. MicroRNA (Shariqah, United Arab Emirates), 8(3), 206–215. https://doi.org/10.2174/1573399815666190115151500
   PubMedGoogle Scholar
• Hou, C. G., Luo, X. Y., & Li, G. (2016). Diagnostic and prognostic value of serum microRNA-206 in patients with gastric cancer. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 39(4), 1512–1520. https://doi.org/10.1159/000447854
   PubMedGoogle Scholar
• Huang, X., Chen, X., Chen, X., & Wang, W. (2022). Screening of serum miRNAs as diagnostic biomarkers for lung cancer using the minimal-redundancy-maximal-relevance algorithm and random forest classifier based on a public database. Public Health Genomics, 2, 1–9. https://doi.org/10.1159/000525316
   Google Scholar
• Huang, X., Zhu, X., Yu, Y., Zhu, W., Jin, L., Zhang, X., Li, S., Zou, P., Xie, C., & Cui, R. (2021). Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Letters, 501, 66–82. https://doi.org/10.1016/j.canlet.2020.12.025
   PubMed Web of Science ®Google Scholar
• Hussein, N. A., Kholy, Z. A., Anwar, M. M., Ahmad, M. A., & Ahmad, S. M. (2017). Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer. Journal of Cancer Research and Clinical Oncology, 143(1), 83–93. https://doi.org/10.1007/s00432-016-2248-7
   PubMed Web of Science ®Google Scholar
• Jamali, L., Tofigh, R., Tutunchi, S., Panahi, G., Borhani, F., Akhavan, S., Nourmohammadi, P., Ghaderian, S. M. H., Rasouli, M., & Mirzaei, H. (2018). Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers. Journal of Cellular Physiology, 233(11), 8538–8550. https://doi.org/10.1002/jcp.26850
   PubMed Web of Science ®Google Scholar
• Jiang, C., Hu, X., Alattar, M., & Zhao, H. (2014). miRNA expression profiles associated with diagnosis and prognosis in lung cancer. Expert Review of Anticancer Therapy, 14(4), 453–461. https://doi.org/10.1586/14737140.2013.870037
   PubMed Web of Science ®Google Scholar
• Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020). Role of PI3K/AKT pathway in cancer: The framework of malignant behavior. Molecular Biology Reports, 47(6), 4587–4629. https://doi.org/10.1007/s11033-020-05435-1
   PubMed Web of Science ®Google Scholar
• Kashyap, D., & Kaur, H. (2020). Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction. Life Sciences, 246, 117417. https://doi.org/10.1016/j.lfs.2020.117417
   Web of Science ®Google Scholar
• Kohama, I., Asano, N., Matsuzaki, J., Yamamoto, Y., Yamamoto, T., Takahashi, R. U., Kobayashi, E., Takizawa, S., Sakamoto, H., Kato, K., Fujimoto, H., Chikuda, H., Kawai, A., & Ochiya, T. (2021). Comprehensive serum and tissue microRNA profiling in dedifferentiated liposarcoma. Oncology Letters, 22(2), 623. https://doi.org/10.3892/ol.2021.12884
   Web of Science ®Google Scholar
• Kong, Y., Ning, L., Qiu, F., Yu, Q., & Cao, B. (2019). Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer. Cancer Biomarkers: Section A of Disease Markers, 24(4), 477–483. https://doi.org/10.3233/CBM-182213
   PubMed Web of Science ®Google Scholar
• Kosela-Paterczyk, H., Paziewska, A., Kulecka, M., Balabas, A., Kluska, A., Dabrowska, M., Piatkowska, M., Zeber-Lubecka, N., Ambrozkiewicz, F., Karczmarski, J., Mikula, M., Rutkowski, P., & Ostrowski, J. (2020). Signatures of circulating microRNA in four sarcoma subtypes. Journal of Cancer, 11(4), 874–882. https://doi.org/10.7150/jca.34723
   Web of Science ®Google Scholar
• Khezri, M. R., Jafari, R., Yousefi, K., & Zolbanin, N. M. (2022). The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions. Experimental and Molecular Pathology, 127, 104787. https://doi.org/10.1016/j.yexmp.2022.104787
   Web of Science ®Google Scholar
• Le, T. A. H., & Lao, T. D. (2022). Circulating microRNAs as the potential diagnostic and prognostic biomarkers for nasopharyngeal carcinoma. Genes, 13(7), 1160. https://doi.org/10.3390/genes13071160
   Web of Science ®Google Scholar
• Letelier, P., Riquelme, I., Hernández, A. H., Guzmán, N., Farías, J. G., & Roa, J. C. (2016). Circulating microRNAs as biomarkers in biliary tract cancers. International Journal of Molecular Sciences, 17(5), 791. https://doi.org/10.3390/ijms17050791
   Web of Science ®Google Scholar
• Li, H., Ma, L., Luo, F., Liu, W., Li, N., Hu, T., Zhong, H., Guo, Y., & Hong, G. (2023). Construct of qualitative diagnostic biomarkers specific for glioma by pairing serum microRNAs. BMC Genomics. 24(1), 96. https://doi.org/10.1186/s12864-023-09203-w
   Web of Science ®Google Scholar
• Lin, G. B., Zhang, C. M., Chen, X. Y., Wang, J. W., Chen, S., Tang, S. Y., & Yu, T. Q. (2019). Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer. Mathematical Biosciences and Engineering: MBE, 17(1), 834–844. https://doi.org/10.3934/mbe.2020044
   PubMed Web of Science ®Google Scholar
• Liu, H. N., Wu, H., Tseng, Y. J., Chen, Y. J., Zhang, D. Y., Zhu, L., Dong, L., Shen, X. Z., & Liu, T. T. (2018). Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer. BMC Cancer, 18(1), 415. https://doi.org/10.1186/s12885-018-4343-4
   PubMedGoogle Scholar
• Mar-Aguilar, F., Rodríguez-Padilla, C., & Reséndez-Pérez, D. (2014). Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers. Methods in Molecular Biology (Clifton, N.J.), 1165, 71–80. https://doi.org/10.1007/978-1-4939-0856-1_6
   PubMedGoogle Scholar
• Marrugo-Ramírez, J., Mir, M., & Samitier, J. (2018). Blood-based cancer biomarkers in liquid biopsy: A promising non-invasive alternative to tissue biopsy. International Journal of Molecular Sciences, 19(10), 2877. https://doi.org/10.3390/ijms19102877
   PubMed Web of Science ®Google Scholar
• Matsuzaki, J., & Ochiya, T. (2020). Circulating microRNAs: Next-generation cancer detection. The Keio Journal of Medicine, 69(4), 88–96. https://doi.org/10.2302/kjm.2019-0011-OA
   Web of Science ®Google Scholar
• Miyoshi, J., Zhu, Z., Luo, A., Toden, S., Zhou, X., Izumi, D., Kanda, M., Takayama, T., Parker, I. M., Wang, M., Gao, F., Zaidi, A. H., Baba, H., Kodera, Y., Cui, Y., Wang, X., Liu, Z., & Goel, A. (2022). A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: A retrospective, prospective and multicenter study. Molecular Cancer, 21(1), 44. https://doi.org/10.1186/s12943-022-01507-x
   Web of Science ®Google Scholar
• Musaddaq, G., Shahzad, N., Ashraf, M. A., & Arshad, M. I. (2019). Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 24(2), 103–109. https://doi.org/10.1080/1354750X.2018.1528631
   PubMed Web of Science ®Google Scholar
• Nagamitsu, Y., Nishi, H., Sasaki, T., Takaesu, Y., Terauchi, F., & Isaka, K. (2016). Profiling analysis of circulating microRNA expression in cervical cancer. Molecular and Clinical Oncology, 5(1), 189–194. https://doi.org/10.3892/mco.2016.875
   PubMedGoogle Scholar
• Necula, L., Matei, L., Dragu, D., Neagu, A. I., Mambet, C., Nedeianu, S., Bleotu, C., Diaconu, C. C., & Chivu-Economescu, M. (2019). Recent advances in gastric cancer early diagnosis. World Journal of Gastroenterology, 25(17), 2029–2044. https://doi.org/10.3748/wjg.v25.i17.2029
   PubMed Web of Science ®Google Scholar
• Niedźwiecki, S., Piekarski, J., Szymańska, B., Pawłowska, Z., & Jeziorski, A. (2018). Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patients. Ginekologia Polska, 89(8), 415–420. https://doi.org/10.5603/GP.a2018.0071
   Web of Science ®Google Scholar
• Noorolyai, S., Shajari, N., Baghbani, E., Sadreddini, S., & Baradaran, B. (2019). The relation between PI3K/AKT signalling pathway and cancer. Gene, 698, 120–128. https://doi.org/10.1016/j.gene.2019.02.076
   PubMed Web of Science ®Google Scholar
• Onishi, M., Ochiya, T., & Tanaka, Y. (2020). MicroRNA and liver cancer. Cancer Drug Resistance (Alhambra, Calif.), 3(3), 385–400. https://doi.org/10.20517/cdr.2019.110
   Google Scholar
• Pan, C., Stevic, I., Müller, V., Ni, Q., Oliveira-Ferrer, L., Pantel, K., & Schwarzenbach, H. (2018). Exosomal microRNAs as tumor markers in epithelial ovarian cancer. Molecular Oncology, 12(11), 1935–1948. https://doi.org/10.1002/1878-0261.12371
   PubMed Web of Science ®Google Scholar
• Piao, X. M., Cha, E. J., Yun, S. J., & Kim, W. J. (2021). Role of exosomal miRNA in bladder cancer: A promising liquid biopsy biomarker. International Journal of Molecular Sciences, 22(4), 1713. https://doi.org/10.3390/ijms22041713
   Web of Science ®Google Scholar
• Polini, B., Carpi, S., Romanini, A., Breschi, M. C., Nieri, P., & Podestà, A. (2019). Circulating cell-free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis. Pigment Cell & Melanoma Research, 32(4), 486–499. https://doi.org/10.1111/pcmr.12755
   Web of Science ®Google Scholar
• Rascio, F., Spadaccino, F., Rocchetti, M. T., Castellano, G., Stallone, G., Netti, G. S., & Ranieri, E. (2021). The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: An updated review. Cancers, 13(16), 3949. https://doi.org/10.3390/cancers13163949
   PubMed Web of Science ®Google Scholar
• Sánchez-Sendra, B., García-Giménez, J. L., González-Muñoz, J. F., Navarro, L., Murgui, A., Terrádez, L., Pinazo, I., Martin, J. M., & Monteagudo, C. (2020). Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging. Journal of the European Academy of Dermatology and Venereology: JEADV, 34(3), e126–e129. https://doi.org/10.1111/jdv.16060
   Web of Science ®Google Scholar
• Seputra, K. P., Purnomo, B. B., Susianti, H., Kalim, H., & Purnomo, A. F. (2021). miRNA-21 as reliable serum diagnostic biomarker candidate for metastatic progressive prostate cancer: Meta-analysis approach. Medical Archives, 75(5), 347–350. https://doi.org/10.5455/medarh.2021.75.347-350
   Google Scholar
• Shi, J., Li, X., Hu, Y., Zhang, F., Lv, X., Zhang, X., Chen, Q., & Hu, S. (2020). MiR-1203 is involved in hepatocellular carcinoma metastases and indicates a poor prognosis. Neoplasma, 67(2), 267–276. https://doi.org/10.4149/neo_2019_190414N328
   PubMed Web of Science ®Google Scholar
• Shi, Q., Feng, K., Xia, L., Wang, C., & Zhu, J. (2019). Combined use of serum miR-499a-5p and CA199 increases the diagnostic sensitivity of pancreatic cancer. Clinical Laboratory, 65(11) https://doi.org/10.7754/Clin.Lab.2019.190416
   Web of Science ®Google Scholar
• Shiao, M. S., Chang, J. M., Lertkhachonsuk, A. A., Rermluk, N., & Jinawath, N. (2021). Circulating exosomal miRNAs as biomarkers in epithelial ovarian cancer. Biomedicines, 9(10), 1433. https://doi.org/10.3390/biomedicines9101433
   Web of Science ®Google Scholar
• Słotwiński, R., Lech, G., & Słotwińska, S. M. (2018). MicroRNAs in pancreatic cancer diagnosis and therapy. Central-European Journal of Immunology, 43(3), 314–324. https://doi.org/10.5114/ceji.2018.80051
   PubMed Web of Science ®Google Scholar
• Smolarz, B., Durczyński, A., Romanowicz, H., Szyłło, K., & Hogendorf, P. (2022). miRNAs in cancer (Review of Literature). International Journal of Molecular Sciences, 23(5), 2805. https://doi.org/10.3390/ijms23052805
   PubMed Web of Science ®Google Scholar
• Smolarz, M., & Widlak, P. (2021). Serum exosomes and their miRNA load-A potential biomarker of lung cancer. Cancers, 13(6), 1373. https://doi.org/10.3390/cancers13061373
   PubMed Web of Science ®Google Scholar
• Sorop, A., Constantinescu, D., Cojocaru, F., Dinischiotu, A., Cucu, D., & Dima, S. O. (2021). Exosomal microRNAs as biomarkers and therapeutic targets for hepatocellular carcinoma. International Journal of Molecular Sciences, 22(9), 4997. https://doi.org/10.3390/ijms22094997
   Web of Science ®Google Scholar
• Sun, R., Zheng, Z., Wang, L., Cheng, S., Shi, Q., Qu, B., Fu, D., Leboeuf, C., Zhao, Y., Ye, J., Janin, A., & Zhao, W. L. (2021). A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: Implications for the roles of MDSC and Th17 cells in lymphoma progression. Molecular Oncology, 15(1), 246–261. https://doi.org/10.1002/1878-0261.12834
   Web of Science ®Google Scholar
• Tito, C., De Falco, E., Rosa, P., Iaiza, A., Fazi, F., Petrozza, V., & Calogero, A. (2021). Circulating microRNAs from the molecular mechanisms to clinical biomarkers: A focus on the clear cell renal cell carcinoma. Genes, 12(8), 1154. https://doi.org/10.3390/genes12081154
   Web of Science ®Google Scholar
• To, K. K., Tong, C. W., Wu, M., & Cho, W. C. (2018). MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World Journal of Gastroenterology, 24(27), 2949–2973. https://doi.org/10.3748/wjg.v24.i27.2949
   PubMed Web of Science ®Google Scholar
• Umezu, T., Tsuneyama, K., Kanekura, K., Hayakawa, M., Tanahashi, T., Kawano, M., Taguchi, Y. H., Toyoda, H., Tamori, A., Kuroda, M., & Murakami, Y. (2020). Comprehensive analysis of liver and blood miRNA in precancerous conditions. Scientific Reports, 10(1), 21766. https://doi.org/10.1038/s41598-020-78500-1
   Web of Science ®Google Scholar
• Usó, M., Jantus-Lewintre, E., Sirera, R., Bremnes, R. M., & Camps, C. (2014). miRNA detection methods and clinical implications in lung cancer. Future Oncology (London, England), 10(14), 2279–2292. https://doi.org/10.2217/fon.14.93
   PubMed Web of Science ®Google Scholar
• Usuba, W., Urabe, F., Yamamoto, Y., Matsuzaki, J., Sasaki, H., Ichikawa, M., Takizawa, S., Aoki, Y., Niida, S., Kato, K., Egawa, S., Chikaraishi, T., Fujimoto, H., & Ochiya, T. (2019). Circulating miRNA panels for specific and early detection in bladder cancer. Cancer Science, 110(1), 408–419. https://doi.org/10.1111/cas.13856
   PubMed Web of Science ®Google Scholar
• Vykoukal, J., Fahrmann, J. F., Patel, N., Shimizu, M., Ostrin, E. J., Dennison, J. B., Ivan, C., Goodman, G. E., Thornquist, M. D., Barnett, M. J., Feng, Z., Calin, G. A., & Hanash, S. M. (2022). Contributions of circulating microRNAs for early detection of lung cancer. Cancers, 14(17), 4221. https://doi.org/10.3390/cancers14174221
   Web of Science ®Google Scholar
• Wang, H., Peng, R., Wang, J., Qin, Z., & Xue, L. (2018). Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage. Clinical Epigenetics, 10(1), 59. https://doi.org/10.1186/s13148-018-0492-1
   PubMedGoogle Scholar
• Wang, S., Zou, C., Lin, X., Hu, D., Su, Y., He, H., Zheng, X., Zhang, L., Huang, T., Liao, J. R., & Lin, X. (2023). RNU12 inhibits gastric cancer progression via sponging miR-575 and targeting BLID. Scientific Reports, 13(1), 7523. https://doi.org/10.1038/s41598-023-34539-4
   Web of Science ®Google Scholar
• Wang, Y. N., Xu, F., Zhang, P., Wang, P., Wei, Y. N., Wu, C., & Cheng, S. J. (2019). MicroRNA-575 regulates development of gastric cancer by targeting PTEN. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 113, 108716. https://doi.org/10.1016/j.biopha.2019.108716
   Web of Science ®Google Scholar
• Wei, J., Yang, L., Wu, Y. N., & Xu, J. (2020). Serum miR-1290 and miR-1246 as potential diagnostic biomarkers of human pancreatic cancer. Journal of Cancer, 11(6), 1325–1333. https://doi.org/10.7150/jca.38048
   Web of Science ®Google Scholar
• Yan, Q., Hu, D., Li, M., Chen, Y., Wu, X., Ye, Q., Wang, Z., He, L., & Zhu, J. (2020). The serum MicroRNA signatures for pancreatic cancer detection and operability evaluation. Frontiers in Bioengineering and Biotechnology, 8, 379. https://doi.org/10.3389/fbioe.2020.00379
   Web of Science ®Google Scholar
• Yan, S., Tang, Z., Chen, K., Liu, Y., Yu, G., Chen, Q., Dang, H., Chen, F., Ling, J., Zhu, L., Huang, A., & Tang, H. (2018). Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. Journal of Experimental & Clinical Cancer Research, 37(1), 214. https://doi.org/10.1186/s13046-018-0853-9
   PubMedGoogle Scholar
• Yang, J., Nie, J., Ma, X., Wei, Y., Peng, Y., & Wei, X. (2019). Targeting PI3K in cancer: Mechanisms and advances in clinical trials. Molecular Cancer, 18(1), 26. https://doi.org/10.1186/s12943-019-0954-x
   PubMed Web of Science ®Google Scholar
• Yang, J., Xu, R., Wang, C., Qiu, J., Ren, B., & You, L. (2021). Early screening and diagnosis strategies of pancreatic cancer: A comprehensive review. Cancer Communications (London, England), 41(12), 1257–1274. https://doi.org/10.1002/cac2.12204
   Web of Science ®Google Scholar
• Yoshida, K., Yokoi, A., Kato, T., Ochiya, T., & Yamamoto, Y. (2020). The clinical impact of intra- and extracellular miRNAs in ovarian cancer. Cancer Science, 111(10), 3435–3444. https://doi.org/10.1111/cas.14599
   PubMed Web of Science ®Google Scholar
• Zhang, A., & Hu, H. (2022). A novel blood-based microRNA diagnostic model with high accuracy for multi-cancer early detection. Cancers, 14(6), 1450.https://doi.org/10.3390/cancers14061450
   Web of Science ®Google Scholar
• Zhang, K., Wang, Y. Y., Xu, Y., Zhang, L., Zhu, J., Si, P. C., Wang, Y. W., & Ma, R. (2021). A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer. Pathology, Research and Practice, 222, 153458. https://doi.org/10.1016/j.prp.2021.153458
   Web of Science ®Google Scholar
• Zhang, L., Xu, Y., Jin, X., Wang, Z., Wu, Y., Zhao, D., Chen, G., Li, D., Wang, X., Cao, H., Xie, Y., & Liang, Z. (2015). A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer. Breast Cancer Research and Treatment, 154(2), 423–434. https://doi.org/10.1007/s10549-015-3591-0
   PubMed Web of Science ®Google Scholar
• Zhao, C., Lu, F., Chen, H., Zhao, F., Zhu, Z., Zhao, X., & Chen, H. (2016). Clinical significance of circulating miRNA detection in lung cancer. Medical Oncology, 33(5), 41. https://doi.org/10.1007/s12032-016-0757-5
   Web of Science ®Google Scholar
• Zhao, L., Liang, X., Wang, L., & Zhang, X. (2022). The role of miRNA in ovarian cancer: An overview. Reproductive Sciences (Thousand Oaks, Calif.), 29(10), 2760–2767. https://doi.org/10.1007/s43032-021-00717-w
   Web of Science ®Google Scholar
• ZiaSarabi, P., Sorayayi, S., Hesari, A., & Ghasemi, F. (2019). Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer. Journal of Cellular Biochemistry, 120(8), 12376–12381. https://doi.org/10.1002/jcb.28503
   Web of Science ®Google Scholar
• Zou, X., Wei, J., Huang, Z., Zhou, X., Lu, Z., Zhu, W., & Miao, Y. (2019). Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Cancer Medicine, 8(6), 2810–2822. https://doi.org/10.1002/cam4.2145
   Web of Science ®Google Scholar